Sort by
Keyphrases
Biofilm Production
75%
Clinical Strains
75%
Vulvovaginal Candidiasis
75%
Resistence
75%
Pathogenicity
75%
Candida
75%
Microorganisms
75%
Candida Albicans (C. albicans)
75%
Fluconazole
62%
Biofilm Formation
50%
Recurrent Candidiasis
50%
Vaginal mucosa
50%
Virulence
50%
Free State
37%
Planktonic State
37%
Proteomics
37%
C.albicans
37%
Skin Infection
37%
Extracellular Polysaccharide
37%
Resistance to Antimicrobials
37%
Human Microbiota
37%
Antimicrobial
37%
Immune System
37%
Commensal Yeast
37%
Biofilm
37%
Amphotericin B
37%
Azoles
37%
Drug Use
37%
Subcutaneous Infection
37%
Evade
37%
Systemic Infection
37%
Resistance Mechanisms
37%
Clinically Significant
37%
Biofilm Synthesis
24%
Miconazole
24%
Gynecologist
24%
Nystatin
24%
Microtitration
24%
MALDI-TOF Mass Spectrometry
24%
Production Capacity
24%
Gene Expression
24%
Medical Center
24%
Minimum Inhibitory Concentration
24%
Susceptibility Analysis
24%
Itraconazole
24%
Pharmacology, Toxicology and Pharmaceutical Science
Candida
75%
Pathogenicity
75%
Vagina Candidiasis
75%
Candida albicans
75%
Candidiasis
50%
Microorganism
50%
Infection
49%
Fluconazole
49%
Nystatin
24%
Miconazole
24%
Minimum Inhibitory Concentration
24%
Itraconazole
24%
Polysaccharide
24%
Skin Infection
24%
Microflora
24%
Antiinfective Agent
24%
Pyrrole Derivative
24%
Sepsis
24%
Amphotericin B
24%
Immunology and Microbiology
Biofilm
100%
Candida albicans
75%
Candida
75%
Pathogenicity
75%
Microorganism
50%
Proteomics
24%
Microflora
24%
Immune System
24%
Minimum Inhibitory Concentration
15%
Matrix-Assisted Laser Desorption-Ionization
15%
Mucosa
15%
Vagina Mucosa
15%